Sign in
Taking people in United StatesPhase 4

Midodrine for low blood pressure on standing after spinal cord injury

Tests midodrine and other treatments for low blood pressure in people with spinal cord injury.

Key facts

Who runs it
James J. Peters Veterans Affairs Medical Center
Where
The Bronx and West Orange, United StatesSee the 2 sites
Trial code
Registry title
Treatment of Orthostatic Hypotension in SCI
Status
Recruiting
Phase
Phase 4
People taking part
25 people, planned
Started
1 Jul 2023
Expected to end
30 Jun 2027
Type of study
Interventional, 2 groups
Treatments tested
  • Midodrine Hydrochloride
Record updated
10 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a spinal cord injury caused by trauma who have low blood pressure. It tests midodrine, droxidopa and compression garments.

Age
18 Years to 60 Years
Sex
All sexes can join.
Disease stage
Traumatic spinal cord injury at level C1-T6, AIS grade A, B or C, at least 12 months after the injury. People must be unable to walk and must not need a breathing machine (ventilator).

Main reasons for not taking part

  • Active mental health disorder, Alzheimer's disease or dementia
  • Stroke, brain blood vessel disease, or another nerve disease besides the spinal cord injury
  • Uncontrolled heart rhythm problems
  • Body-wide, liver or kidney disease, or known or suspected cancer
  • Self-reported 3 or more episodes of autonomic dysreflexia (sudden blood pressure spikes) per day

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • traumatic spinal cord injury
  • at least 12 months post injury
  • injury level of C1-T6
  • AIS A, B or C
  • non-ambulatory
  • non-ventilator

Who cannot take part

  • Concurrent systemic, hepatic, or renal disease
  • Active psychiatric disorder
  • Stroke or cerebrovascular disease
  • Alzheimer's Disease or dementia
  • Unmanaged cardiac arrhythmias
  • Suspected or diagnosed malignancy
  • Neurological disease other than SCI
  • Self-reported history of three or more symptomatic episodes of AD per day

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 60 years old?

Where in United States

  • James J Peters VA Medical CenterThe Bronx, United StatesContact: Dylan C Arnero, MATaking people
  • Kessler FoundationWest Orange, United StatesContact: Matthew T Maher, MSTaking people

About the trial

What the trial wants to find out

The purpose of this study is to identify the effects of non-pharmacological and pharmacological anti-hypotensive treatment interventions on orthostatic hemodynamic responses, symptoms of autonomic dysreflexia and orthostatic hypotension, and levels of fatigue and comfort in hypotensive individuals with SCI.

The 2 groups in the trial

  • Study 1Treatment being tested

    Twenty-five participants will be asked to visit the laboratory on 6 occasions, for an open-label, dose escalation trial to determine the effect of midodrine and droxidopa on supine and seated blood pressure and on symptoms of autonomic dysreflexia and orthostatic hypotension.

    Treatment: Midodrine Hydrochloride

  • Study 2Treatment being tested

    Determine the effects of compression garments, midodrine, and droxidopa, compared to placebo, on orthostatic hemodynamics, symptoms of AD and OH and reporting of fatigue and thermal comfort.

    Treatment: Midodrine Hydrochloride

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Treatment of Orthostatic Hypotension in Individuals With Spinal Cord Injury
Plain-language title
Midodrine for low blood pressure on standing after spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05839652, who can take part
Record updated
10 August 2026